COLORADO SPRINGS, Colo., Oct. 19 /PRNewswire-FirstCall/ -- Spectranetics Corporation today announced that the Company will release 2007 third quarter financial results prior to market open on Wednesday, October 31, 2007. Company management will host an investment-community conference call beginning at 9:00 a.m. Mountain Time (11:00 a.m. Eastern Time) on Wednesday, October 31 to discuss those results and to answer questions.
Please note that the release of quarterly results is one week later than the Company’s traditional reporting date in order to accommodate management’s attendance and participation in the TCT conference being held next week in Washington, D.C.
Individuals interested in listening to the conference call may do so by dialing (888) 803-8271 for domestic callers, or (706) 634-2467 for international callers, or from the webcast on the investor relations section of the Company’s Web site at http://www.spectranetics.com.
A 48-hour telephone replay will be available approximately one hour after the conclusion of the call by dialing (800) 642-1687 for domestic callers, or (706) 645-9291 for international callers, and entering reservation code 21369177. The webcast will be available on the Company’s Web site for 14 days following the completion of the call.
About Spectranetics
Founded in 1984, Spectranetics manufactures and sells the only excimer laser approved in the United States, Europe and Japan for use in minimally invasive cardiovascular procedures. This technology treats complex cardiovascular conditions by photo-ablating multiple lesion types into tiny particles that are easily absorbed into the blood stream. The Company’s disposable catheters use high-energy “cool” ultraviolet light to vaporize arterial blockages in the legs and heart, as well as scar tissue encapsulating pacing and defibrillation leads. For more information, visit http://www.spectranetics.com.
dmarkley@lhai.com
CONTACT: John Schulte, Chief Executive Officer, or Guy Childs, Chief
Financial Officer, +1-719-633-8333, both of Spectranetics Corporation; or
investors & media, Don Markley, dmarkley@lhai.com, or Bruce Voss, both of
Lippert-Heilshorn & Associates, Inc., +1-310-691-7100, for Spectranetics
Corporation
Web site: http://www.spectranetics.com/
